Monday, July 18, 2016

UPDATE 1-AstraZeneca's lung cancer drug meets main goal in late-stage trial

July 18 (Reuters) - AstraZeneca Plc said its

experimental lung cancer drug Tagrisso met its main goal in a

late-stage study.

Read more

No comments:

Post a Comment